What is Lynx?
Lynx.MD operates as a sophisticated medical data science platform, facilitating access to crucial health research data. Based in Palo Alto, California, the company's core mission revolves around enabling the development of advanced diagnostic and therapeutic solutions. By leveraging its platform, Lynx.MD aims to bridge the gap between raw health data and actionable medical insights, positioning itself as a key player in the health tech sector.
How much funding has Lynx raised?
Lynx has raised a total of $12M across 1 funding round:
Angel/Seed
$12M
Angel/Seed (2021): $12M with participation from Triventures, New York Life Ventures, MizMaa, UpWest, iAngels, and Amdocs
Key Investors in Lynx
Triventures
Triventures is a global venture capital fund that invests in early-stage companies with innovative breakthroughs in healthcare and other industries. The firm focuses on bio-convergence and data-driven technologies, partnering with exceptional entrepreneurs to drive transformative solutions.
MizMaa
MizMaa Ventures is an early-stage venture capital firm that invests in Israeli entrepreneurs developing deep-technology solutions. The firm provides long-term investment capital, expert advice, and meaningful connections to help founders build successful global companies.
iAngels
iAngels is a venture capital firm and investment platform offering accredited investors worldwide exclusive access to tech startups and scaleup investment opportunities originated in Israel. They provide curated investment opportunities and partner with high-caliber entrepreneurs.
What's next for Lynx?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Lynx.MD. This capital infusion is expected to accelerate the platform's development, enhance its data analytics capabilities, and expand its reach within the healthcare research community. The company is poised to further its mission of empowering the creation of innovative diagnostic and therapeutic tools, potentially marking a significant advancement in personalized medicine and clinical research.
See full Lynx company page
